PGNY
Progyny, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 28 ▼ Progyny reported Q1 2026 EPS of $0.29 on revenue of $348.6M, sharply…
- Jun 2 to Jun 4 ▼ 3 days of insider sells: $116.5K by 2 insiders, avg $25.36
- Jul 14 ▼ 1 insider sell $70.9K at $31.60
- Sep 10 ▼ 1 insider sell $311.9K at $27.12
- Sep 23 ▼ 1 insider sell $101.9K at $26.10
- Sep 30 Wells Fargo initiates
- Oct 14 ▼ 1 insider sell $52.6K at $28.00
- Oct 26 FDA: New Progyny Study Finds Significant Improvement in Menopau…
- Nov 4 to Nov 11 ▼ 5 days of insider sells: $21.9M by 4 insiders, avg $35.72
- Nov 4 ▲ Progyny reported Q3 2026 revenue of $341.3M (+8.9% YoY) and GAAP EPS…
- Nov 4 ▲ Progyny reported Q3 2026 revenue of $341.3M (+8.9% YoY) and adjusted…
- Nov 4 ▲ Earnings: PGNY Q3 2026 Earnings: EPS $0.52 (+62.7% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
7 insiders sold $22.5M.
- InstitutionsMIXED
Q3 2026: 19 added (0 new), 28 trimmed or exited.
- AnalystsBULLISH
15 of 18 rate it Buy or better.
- Short sellersSTEADY
Short interest −1.9% to 4.76M shares. 6.3 days to cover, ≈6.5% of shares.
- TrendUPTREND
29% above its 50-day average. New closing high $37.15 on Nov 16.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| AMERICAN CENTURY COMPANIES INC | DOUBLED | $65.1M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $63.0M |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | TRIM | $41.2M |
| Neuberger Berman Group LLC | DOUBLED | $14.2M |
| Qube Research & Technologies Ltd | DOUBLED | $12.3M |
| FIRST TRUST ADVISORS LP | DOUBLED | $10.7M |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $7.3M |
| SEI INVESTMENTS CO | ADD | $5.2M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
18 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | JP Morgan MAINTAIN | Neutral |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 5, 2026 | Wells Fargo MAINTAIN | Overweight |
| Nov 5, 2026 | Citizens MAINTAIN | Market Outperform |
| Nov 5, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
| Sep 30, 2026 | Wells Fargo INITIATE | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Clapp Geoffrey Chief Product Officer Nov 11, 2026 | SELL | $28.2K |
Schlanger David J Executive Chairman Nov 10, 2026 | EXERCISE | $32.2K |
Schlanger David J Executive Chairman Nov 10, 2026 | SELL | $1.3M |
Anevski Peter CHIEF EXECUTIVE OFFICER Nov 10, 2026 | EXERCISE | $168.5K |
Anevski Peter CHIEF EXECUTIVE OFFICER Nov 10, 2026 | SELL | $4.3M |
Anevski Peter CHIEF EXECUTIVE OFFICER Nov 10, 2026 | SELL | $2.4M |
Anevski Peter CHIEF EXECUTIVE OFFICER Nov 10, 2026 | SELL | $1.2M |
Anevski Peter CHIEF EXECUTIVE OFFICER Nov 10, 2026 | SELL | $655.3K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
25 filings · 1 press release · 2 bullish · 3 bearish · 20 neutral- NEUTRAL CLUSTERNov 13, 2026
Four Progyny insiders, including the CEO, Executive Chairman, and CFO, sold shares in open-market…
The sales are small relative to market cap and all under 10b5-1 plans, so no bearish signal. Monitor the next 10-Q for any change in insider selling patterns or plan modifications.
- BEARISH CLUSTERNov 12, 2026
Three PGNY insiders (CEO, Executive Chairman, CFO) sold a total of $10.33M in open-market sales…
The CEO and Chairman sold a combined $10.3M post-earnings despite strong results and raised guidance. While all sales were under 10b5-1 plans, the size and timing (immediately after a positive…
- NEUTRAL 144Nov 12, 2026
Geoffrey Clapp, an officer of Progyny, filed a Form 144 notice of intent to sell 774 shares of…
The filing is a routine insider intent-to-sell notice for a very small number of shares. No material impact expected. Monitor future Form 4 filings to confirm whether the sale was executed.
- NEUTRAL 144Nov 10, 2026
Peter Anevski, a director and officer of Progyny, filed a Form 144 notice of intent to sell 50,139…
The sale is part of a pre-arranged 10b5-1 plan adopted in July 2026, reducing the signal value. However, the cumulative insider selling volume ($11.9M in 30 days) is notable for a $2.6B market cap…
All PGNY filing & press-release reports (26)
- CLUSTER reportNov 13, 2026
- CLUSTER reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 10, 2026
- CLUSTER reportNov 9, 2026
- 144 reportNov 5, 2026
- 144 reportNov 5, 2026
- 144 reportNov 5, 2026
- 8-K reportNov 4, 2026
- PRESS-RELEASE reportNov 4, 2026
- 144 reportNov 4, 2026
- SC 13G/A reportOct 27, 2026
- PRESS-RELEASE reportOct 26, 2026
- PRESS-RELEASE reportOct 21, 2026
- 144 reportSep 10, 2026
- PRESS-RELEASE reportJul 23, 2026
- INST-CLUSTER reportJun 12, 2026
- CLUSTER reportJun 3, 2026
- CLUSTER reportJun 3, 2026
- PRESS-RELEASE reportMay 28, 2026
- 144 reportMay 27, 2026
- CLUSTER reportMay 21, 2026
- 8-K reportMay 26, 2026
- CLUSTER reportMay 21, 2026
- PRESS-RELEASE reportApr 23, 2026
- DEFA14A reportApr 10, 2026